Progression rate from new-onset pre-hypertension to hypertension in Korean adults

Circulation Journal

Volumn 75, Issue 1, 2011, Pages 135-140

  Kim, Soo Jeong ^a   Lee, Jakyoung ^b   Nam, Chung Mo ^c   Jee, Sun Ha ^b   Park, Il Soo ^d   Lee, Kyung Jong ^a   Lee, Soon Young ^a  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Health Insurance Policy Research Institute   (South Korea)

Author keywords

Epidemiology; Follow up studies; Hypertension; Population

Indexed keywords

ADULT; ADULTHOOD; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PERIODIC MEDICAL EXAMINATION; PREHYPERTENSION; SEX DIFFERENCE; SMOKING HABIT;

ADULT; AGE DISTRIBUTION; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; PREHYPERTENSION; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; TIME FACTORS;

EID: 78651243920     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0948     Document Type: Article

References (22)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572.
2. Lenfant C, Chobanian AV, Jones DW, Roccella EJ.; Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): Resetting the hypertension sails. Hypertension 2003; 41: 1178-1179.
3. European Society of Hypertension-European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
4. Kokubo Y, Kamide K. High-normal blood pressure and the risk of cardiovascular disease. Circ J 2009; 73: 1381-1385.
5. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.
6. Li H, Xu T, Tong W, Liu Y, Zhao L, Zhang Y. Comparison of cardiovascular risk factors between prehypertension and hypertension in a Mongolian population, Inner Mongolia, China. Circ J 2008; 72: 1666-1673.
7. Kario K. Orthostatic hypertension: A measure of blood pressure variation for predicting cardiovascular risk. Circ J 2009; 73: 1002-1007.
8. Zhang M, Batu B, Tong W, Li H, Lin Z, Li Y, et al. Prehyperten-sion and cardiovascular risk factor clustering among Mongolian population in rural and animal husbandry area, Inner Mongolia, China. Circ J 2009; 73: 1437-1441.
9. Leitschuh M, Cupples LA, Kannel W, Gagnon D, Chobanian A. High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension 1991; 17: 22-27.
10. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet 2001; 358: 1682-1686.
11. Winegarden CR. From "Prehypertension" to Hypertension? Additional Evidence. Ann Epidemiol 2005; 15: 720-725.
12. Zhang H, Thijs L, Kuznetsova T, Fagard RH, Li X, Staessen JA. Progression to hypertension in the non-hypertensive participants in the Flemish Study on Environment, Genes and Health Outcomes. J Hypertens 2006; 24: 1719-1727.
13. Hansen TW, Staessen JA, Zhang H, Torp-Pedersen C, Rasmussen S, Thijs L, et al. Cardiovascular outcome in relation to progression to hypertension in the Copenhagen MONICA cohort. Am J Hyper-tens 2007; 20: 483-491.
14. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Incidence of hypertension and risk of cardiovascular events among ethnic Chinese: Report from a community-based cohort study in Taiwan. J Hypertens 2007; 25: 1355-1361.
15. Kim J, Kim E, Yi H, Joo S, Shin K, Kim J, et al. Short-term incidence rate of hypertension in Korea middle-aged adults. J Hyper-tens 2006; 24: 2177-2182.
16. Jimenez-Corona A, Lopez-Ridaura R, Stern MP, Gonzalez-Villalpando C. Risk of progression to hypertension in a low-income Mexican population with prehypertension and normal blood pressure. Am J Hypertens 2007; 20: 929-936.
17. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 2004; 164: 2113-2118.
18. Liszka HA, Mainous AG 3rd, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med 2005; 3: 294-299.
19. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 2006; 119: 133-141.
20. Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005; 36: 1859-1863.
21. Mainous AG 3rd, Everett CJ, Liszka H, King DE, Egan BM. Pre-hypertension and mortality in a nationally representative cohort. Am J Cardiol 2004; 94: 1496-1500.
22. Jee SH, Suh I, Kim IS, Appel LJ. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: The Korea Medical Insurance Corporation Study. JAMA 1999; 282: 2149-2155.